Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2018 Jan 1;29(1):8-11.
doi: 10.1093/annonc/mdx650.

Monitoring resistance through liquid biopsy

A R Parikh  1   2 , R B Corcoran  1   2
Affiliations
Comment

Monitoring resistance through liquid biopsy

A R Parikh et al. Ann Oncol. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
RAS mutations detected at progression in tumor versus plasma. Percentage of patients with emergent RAS mutations detected after progression in panitumumab in tumor biopsies (blue) or plasma cfDNA (red). Values are shown for all patients (left), and for patients with paired tumor and plasma specimens obtained at progression.
See this image and copyright information in PMC

Comment on

References

    1. Siena S, Sartore-Bianchi A, Garcia-Carbonero R. et al. Dynamic molecular analysis and clinical correlates of tumor evolution within a phase II trial of panitumumab-based therapy in metastatic colorectal cancer. Ann Oncol 2018; 29(1): 119–126. - PMC - PubMed
    1. Haber DA, Velculescu VE.. Blood-based analyses of cancer: circulating tumor cells and circulating tumor DNA. Cancer Discov 2014; 4(6): 650–661. - PMC - PubMed
    1. Gerlinger M, Rowan AJ, Horswell S. et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 2012; 366(10): 883–892. - PMC - PubMed
    1. Gerlinger M, Horswell S, Larkin J. et al. Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing. Nat Genet 2014; 46(3): 225–233. - PMC - PubMed
    1. McGranahan N, Swanton C.. Biological and therapeutic impact of intratumor heterogeneity in cancer evolution. Cancer Cell 2015; 27(1): 15–26. - PubMed

Publication types